Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
91.66
USD
|
+0.42%
|
|
+7.48%
|
+46.33%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,612
|
8,496
|
8,834
|
4,380
|
7,526
|
11,205
|
-
|
-
|
Enterprise Value (EV)
1 |
2,295
|
8,011
|
8,250
|
3,843
|
6,997
|
10,793
|
10,701
|
10,446
|
P/E ratio
|
-18.8
x
|
-35
x
|
-17.9
x
|
-7.21
x
|
-16.6
x
|
-39.6
x
|
-78.5
x
|
-941
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
8.64
x
|
21.7
x
|
14.1
x
|
5.34
x
|
6.95
x
|
8.36
x
|
7.06
x
|
6.03
x
|
EV / Revenue
|
7.59
x
|
20.5
x
|
13.2
x
|
4.69
x
|
6.46
x
|
8.06
x
|
6.74
x
|
5.62
x
|
EV / EBITDA
|
-18.7
x
|
-38.6
x
|
-18.1
x
|
-7.33
x
|
-16.6
x
|
-41.2
x
|
-92.9
x
|
363
x
|
EV / FCF
|
-33.5
x
|
-39.6
x
|
-21.4
x
|
-8.02
x
|
-24.5
x
|
-95
x
|
299
x
|
55.5
x
|
FCF Yield
|
-2.98%
|
-2.52%
|
-4.66%
|
-12.5%
|
-4.09%
|
-1.05%
|
0.33%
|
1.8%
|
Price to Book
|
9.43
x
|
16.6
x
|
13.6
x
|
6.33
x
|
9.79
x
|
16.3
x
|
15.2
x
|
11.8
x
|
Nbr of stocks (in thousands)
|
77,529
|
85,370
|
94,595
|
109,033
|
120,152
|
122,242
|
-
|
-
|
Reference price
2 |
33.69
|
99.52
|
93.39
|
40.17
|
62.64
|
91.66
|
91.66
|
91.66
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
302.3
|
391
|
625.5
|
820.2
|
1,083
|
1,340
|
1,588
|
1,858
|
EBITDA
1 |
-122.9
|
-207.7
|
-456.9
|
-524.3
|
-422.1
|
-261.7
|
-115.2
|
28.76
|
EBIT
1 |
-130.7
|
-216.3
|
-468.2
|
-541
|
-446.2
|
-289.4
|
-149.8
|
-22.9
|
Operating Margin
|
-43.22%
|
-55.31%
|
-74.85%
|
-65.96%
|
-41.22%
|
-21.6%
|
-9.43%
|
-1.23%
|
Earnings before Tax (EBT)
1 |
-122.8
|
-229.6
|
-471.1
|
-546.8
|
-434.5
|
-280.2
|
-140.8
|
-0.9594
|
Net income
1 |
-124.8
|
-229.7
|
-471.7
|
-547.8
|
-434.8
|
-280.4
|
-141.8
|
-9.844
|
Net margin
|
-41.29%
|
-58.76%
|
-75.42%
|
-66.79%
|
-40.16%
|
-20.93%
|
-8.93%
|
-0.53%
|
EPS
2 |
-1.790
|
-2.840
|
-5.210
|
-5.570
|
-3.780
|
-2.316
|
-1.168
|
-0.0974
|
Free Cash Flow
1 |
-68.41
|
-202.1
|
-384.8
|
-479.2
|
-286.2
|
-113.7
|
35.8
|
188.1
|
FCF margin
|
-22.63%
|
-51.69%
|
-61.52%
|
-58.42%
|
-26.43%
|
-8.48%
|
2.25%
|
10.13%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
654.07%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
158.1
|
173
|
194.1
|
198.2
|
210.6
|
217.3
|
241.8
|
261.4
|
268.3
|
311.1
|
315.7
|
328.1
|
339.1
|
356.3
|
373
|
EBITDA
1 |
-147.2
|
-136.7
|
-134.1
|
-138.5
|
-113.9
|
-137.8
|
-133.2
|
-107.3
|
-104
|
-77.62
|
-90.86
|
-75.32
|
-65.9
|
-54.34
|
-39.34
|
EBIT
1 |
-150.2
|
-139.7
|
-137.1
|
-143.1
|
-119.1
|
-141.8
|
-138.3
|
-112.4
|
-111
|
-84.54
|
-86.7
|
-77.69
|
-68.69
|
-56.82
|
-54.88
|
Operating Margin
|
-94.99%
|
-80.72%
|
-70.64%
|
-72.19%
|
-56.52%
|
-65.26%
|
-57.21%
|
-43.01%
|
-41.36%
|
-27.17%
|
-27.46%
|
-23.68%
|
-20.26%
|
-15.95%
|
-14.72%
|
Earnings before Tax (EBT)
1 |
-151
|
-140.6
|
-138.4
|
-145
|
-121.3
|
-142.2
|
-136.8
|
-111.1
|
-108.8
|
-77.84
|
-86.57
|
-76.84
|
-66.97
|
-53.97
|
-52.51
|
Net income
1 |
-151.3
|
-140.6
|
-138.6
|
-145.2
|
-121.5
|
-142.6
|
-136.9
|
-110.8
|
-109
|
-78.03
|
-86.03
|
-75.6
|
-65.86
|
-53.81
|
-52.57
|
Net margin
|
-95.67%
|
-81.24%
|
-71.39%
|
-73.23%
|
-57.67%
|
-65.63%
|
-56.64%
|
-42.39%
|
-40.64%
|
-25.08%
|
-27.26%
|
-23.05%
|
-19.42%
|
-15.1%
|
-14.1%
|
EPS
2 |
-1.630
|
-1.490
|
-1.450
|
-1.500
|
-1.250
|
-1.370
|
-1.230
|
-0.9700
|
-0.9500
|
-0.6400
|
-0.7183
|
-0.6294
|
-0.5483
|
-0.4432
|
-0.4181
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
2/24/22
|
5/5/22
|
8/4/22
|
11/8/22
|
2/28/23
|
5/9/23
|
8/3/23
|
11/8/23
|
2/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
317
|
485
|
584
|
536
|
529
|
412
|
503
|
758
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-68.4
|
-202
|
-385
|
-479
|
-286
|
-114
|
35.8
|
188
|
ROE (net income / shareholders' equity)
|
-89.6%
|
-60.1%
|
-82.8%
|
-80.6%
|
-59.1%
|
-39.2%
|
-13.8%
|
3.23%
|
ROA (Net income/ Total Assets)
|
-32.7%
|
-30.3%
|
-43.5%
|
-41.6%
|
-30.7%
|
-21.4%
|
-8.6%
|
-1.1%
|
Assets
1 |
381.4
|
757.4
|
1,084
|
1,315
|
1,418
|
1,313
|
1,650
|
894.9
|
Book Value Per Share
2 |
3.570
|
6.000
|
6.870
|
6.340
|
6.400
|
5.640
|
6.050
|
7.760
|
Cash Flow per Share
2 |
-0.9100
|
-2.250
|
-3.700
|
-4.380
|
-2.150
|
-0.2600
|
0.6300
|
2.200
|
Capex
1 |
4.97
|
19.6
|
49.6
|
47.7
|
39.2
|
42.6
|
51.5
|
57.9
|
Capex / Sales
|
1.64%
|
5.01%
|
7.93%
|
5.82%
|
3.62%
|
3.18%
|
3.24%
|
3.12%
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
91.66
USD Average target price
103.1
USD Spread / Average Target +12.50% Consensus |
1st Jan change
|
Capi.
|
---|
| +46.33% | 11.2B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|